Manufacture

Why critical starting materials are crucial to the production of cell and gene therapies, and among them cord blood deserves particular attention

Voting will close on December 21.

From hemispheric analysis to hatchery logistics, there’s a lot more to vaccine production than you might suspect

It’s December – time for The Medicine Maker to welcome you to 2022’s most innovative new technologies in drug development and manufacturing

This free eBook showcases some of our top content covering outsourcing and supply chains.

We all know that automation can reduce human labor, but how else can it make economically viable cell and gene therapies a reality?

Demand for cell and gene therapies is increasing, but are current manufacturing approaches up to the task?

Though key hurdles remain, there is huge potential for mRNA-based therapeutics to tackle areas of unmet need.

Get a sharp perspective on the cell and gene status quo in The Medicine Maker 2022 supplement on advanced medicine

Walking through the mRNA manufacturing process – and its many challenges.